Health TrialsbyHealthPanel

Mobile Geriatric Unit (MGU) to Reduce Hospitalisations in Nursing Home Residents

ConditionsNursing Home CareHospitalisation Prevention
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversität des Saarlandes

About this trial

This prospective observational before-after study evaluates the impact of a Mobile Geriatric Unit (MGU) on hospitalisation rates among nursing home residents. The study includes a 12-month control phase with usual care followed by a 12-month intervention phase during which the MGU is implemented. The MGU provides advanced on-site diagnostics and telemedicine-supported specialist consultation within nursing homes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Residents of participating nursing homes

Informed consent from participant or legal representative

Disqualifiers

Acute life-threatening conditions requiring immediate hospitalisation

Trial population

Residents of participating nursing homes

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Mobile Geriatric Unit (MGU)

    Other intervention

    The MGU is a mobile diagnostic unit providing on-site diagnostics in nursing homes. It includes a 32-slice (64 slice reconstruction) whole body CT scanner, digital X-ray, portable ultrasound, ECG, EEG, and point-of-care laboratory diagnostics. A physician and radiology technician perform diagnostics on-site. Results are transmitted via telemedicine to hospital specialists and communicated to the general practitioner for treatment decisions within 48 hours.

Treatment groups

4,907 Participants
are divided into 2 treatment groups
Group A: Control Phase (Usual Care)0 interventions
Group B: Intervention Phase (MGU)1 intervention

Trial outcomes

Primary outcomes

1

Hospital admissions per person-year

Number of inpatient hospital admissions, excluding elective admissions.

Time frame
Up to 24 months

Secondary outcomes

1

Mortality

Mortality

Time frame
Day 180
2

Functional status; mobility: modified Rankin Scale (mRS)

Modified Rankin Scale (mRS): 0: No symptoms 1. No significant disability 2. Slight disability 3. Moderate disability 4. Moderately severe disability 5. Severe disability 6. Death Minimum value: 0 (best outcome) Maximum value: 6 (worst outcome)

Time frame
Day 180
3

Functional status; frailty: Clinical Frailty Scale

Clinical Frailty Scale (as according to Moorhouse and Rockwood\*): 1. very fit 2. well 3. managing well 4. apparently vulnerable 5. mildly frail 6. moderately frail 7. severely frail 8. very severely frail 9. terminally ill Minimum value: 1 (best outcome) Maximum value: 9 (worst outcome) \* Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb 2012; 42: 333-40

Time frame
Day 180
4

Cognitive status

The cognitive performance assessment is carried out through subjective evaluation by the nursing home's nursing staff at day 180.

Time frame
Day 180

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universität des Saarlandes

Lead sponsor

DIKOM Consortium

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: